Is it true remission? A study of remitted patients affected by schizophrenia and schizoaffective disorders

Andreasen, 2005, Remission in schizophrenia: proposed criteria and rationale for consensus, American Journal of Psychiatry, 162, 441, 10.1176/appi.ajp.162.3.441

Boden, 2009, Association between symptomatic remission and functional outcome in first-episode schizophrenia, Schizophrenia Research, 107, 232, 10.1016/j.schres.2008.10.004

Brissos, 2011, Symptomatic remission in schizophrenia patients: relationship with social functioning, quality of life, and neuro cognitive performance, Schizophrenia Research, 129, 133, 10.1016/j.schres.2011.04.001

Byerly, 2005, A comparison of electronic monitoring vs clinician rating of antipsychotic adherence in outpatients with schizophrenia, Psychiatry Research, 133, 129, 10.1016/j.psychres.2004.11.002

Cannon-Spoor, 1982, Measurement of premorbid adjustment in chronic schizophrenia, Schizophrenia Bulletin, 8, 470, 10.1093/schbul/8.3.470

Carpiniello, B., Pinna, F., Tusconi, M., Zaccheddu, E., Fatteri, F., 2012. Gender differences in remission and recovery of schizophrenic and schizoaffective patients: preliminary results of prospective color study. Schizophrenia Research Treatment, 10.1155/2012/576369. (in Medline the citation is 2012:12:576369 followed by doi)

Conti, 1988

De Hert, 2007, Remission criteria for schizophrenia: evaluation in a large naturalistic cohort, Schizophrenia Research, 92, 68, 10.1016/j.schres.2007.01.010

de Millas, 2006, The impact of subjective well-being under neuroleptic treatment on compliance and remission, Dialogues Clinical Neuroscience, 8, 131, 10.31887/DCNS.2006.8.1/wmillas

Carpiniello, 2002, Clinical and psychosocial outcome of patients affected by panic disorder with or without agorafobia: result of a naturalistic follow-up study, European Psychiatry, 17, 394, 10.1016/S0924-9338(02)00701-0

Eack, 2007, Psychiatric symptoms and quality of life in schizophrenia: a meta-analysis, Schizophrenia Bulletin, 33, 1225, 10.1093/schbul/sbl071

First, 1996

Green, 2000, Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the “right stuff”?, Schizophrenia Bulletin, 26, 119, 10.1093/oxfordjournals.schbul.a033430

Guy, E., ECDEU Assessment Manual for Psychopharmacology Revised, 1976. DHEW Publication, N. (ADM), Washington, pp. 76–338.

Haro, 2003, The clinical global impression-schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia, Acta Psychiatrica Scandinavica Suppl, 416, 16, 10.1034/j.1600-0447.107.s416.5.x

Helldin, 2007, Remission in prognosis of functional outcome: a new dimension in the treatment of patients with psychotic disorders, Schizophrenia Research, 93, 160, 10.1016/j.schres.2007.01.014

Hogan, 1983, A self report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity, Psychological Medicine, 13, 177, 10.1017/S0033291700050182

Kane, 2007, Treatment adherence and long-term outcomes, CNS Spectrum, 12, 21, 10.1017/S1092852900026304

Kay, 1987, The positive and negative syndrome scale (PANSS) for schizophrenia, Schizophrenia Bulletin, 13, 261, 10.1093/schbul/13.2.261

Karow, 2002, Subjective well-being and quality of life under atypical antipsychotic treatment, Psychopharmacology (Berl), 162, 24, 10.1007/s00213-002-1052-z

Karow, 2012, Remitted but still impaired? Symptomatic versus functional remission in patients with schizophrenia, European Psychiatry, 27, 401, 10.1016/j.eurpsy.2011.01.012

Kirkpatrick, 2006, The NIMH-MATRICS Consensus statement on negative symptoms, Schizophrenia Bulletin, 32, 214, 10.1093/schbul/sbj053

Lambert, 2006, Prediction of remission as a combination of symtpmatic and functional remission and adequate subjective well-being in 2690 patients with schizophrenia, Journal of Clinical Psychiatry, 67, 1690, 10.4088/JCP.v67n1104

Levine, 2011, Extent of attaining and maintaining symptom remission by antipsychotic medication in the treatment of chronic schizophrenia: evidence from the CATIE study, Schizophrenia Research, 133, 42, 10.1016/j.schres.2011.09.018

Llorca, 2008, Partial compliance in schizophrenia ant the impact on patient outcomes, Psychiatry Research, 161, 235, 10.1016/j.psychres.2007.07.012

Morosini, 2000, Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning, Acta Psychiatrica Scandinavica, 101, 323, 10.1111/j.1600-0447.2000.tb10933.x

Mueser, 2013, Psychosocial treatments for Schizophrenia, Annual Review Clinical Psychology, 9, 465, 10.1146/annurev-clinpsy-050212-185620

Naber, 2001, Improvement of schizophrenic patients' subjective well-being under atypical antipsychotic drugs, Schizophrenia Research, 50, 79, 10.1016/S0920-9964(00)00166-3

Nasrallah, 2006, Improving patients' outcomes in schizophrenia: achieving remission, Journal of Psychopharmacology, 20, 57, 10.1177/1359786806071248

Oorshot, 2012, Symptomatic remission in psychosis and real life functioning, British Journal of Psychiatry, 10.1192/bjp.bp.111.104414

Primavera, 2012, Does duration of untreated psychosis predict very long term outcome of schizophrenic disorders? Results of a retrospective study, Annals of General Psychiatry, 11, 21, 10.1186/1744-859X-11-21

Schennach-Wolff, 2009, Defining and predicting functional outcome in schizophrenia and schizophrenia-spectrum disorders, Schizophrenia Research, 13, 210, 10.1016/j.schres.2009.05.032

Semisa, 2008, Promoting recovery of schizophrenic patients: discrepancy between routine practice and evidence. The SIEP-DIRECT'S Project, Epidemiologia e Psichiatria Sociale, 14, 331, 10.1017/S1121189X00000130

Spellmann, 2012, One-year functional outcomes of naturalistically treated patients with schizophrenia, Psychiatry Research, 10.1016/j.psychres.2011.12.047

Skevington, 2004, The WHOQoL Group. The World Health Organization's WHOQoL Bref quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQoL group, Quality of Life Research, 13, 299, 10.1023/B:QURE.0000018486.91360.00

Van Os, 2006, Validation of remission criteria for schizophrenia, American Journal of Psychiatry, 163, 2000, 10.1176/ajp.2006.163.11.2000

Wunderink, 2007, Predictive validity of proposed remission criteria in first-episode schizophrenic patients responding to antipsychotics, Schizophrenia Bulletin, 33, 792, 10.1093/schbul/sbl015